You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Solid Tumors with immunotherapy progression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Extracranial Malignant Solid Tumor, Radiotherapy, Immune Checkpoint Blockade Trial in Shantou (Intestinal Low Dose

Not yet recruiting
  • Metastatic Extracranial Malignant Solid Neoplasm
  • +3 more
  • Intestinal Low Dose Radiotherapy-1Gy
  • +3 more
  • Shantou, Guangdong, China
    Cancer Hospital, Shantou University Medical College
Oct 7, 2023

Checkpoint Inhibitors in Solid Tumors:Retrospective Real-world

Recruiting
  • Immunotherapy
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Feb 8, 2023

    Carcinoma, Renal Cell, NSCLC Trial in Belgium, France (Live Bacterial Product - Akkermansia muciniphila)

    Recruiting
    • Carcinoma, Renal Cell
    • Carcinoma, Non-Small-Cell Lung
    • Live Bacterial Product - Akkermansia muciniphila
    • Mons, Belgium
    • +3 more
    May 9, 2023

    Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)

    Recruiting
    • Neuroblastoma
    • +2 more
    • Columbus, Ohio
      Nationwide Children's Hospital
    Dec 20, 2022

    Solid Tumor Trial in Beijing (GLS-012, GLS-010)

    Recruiting
    • Solid Tumor
    • Beijing, China
      Beijing Cancer Hospital
    Jun 11, 2023

    Tumor Infiltrating Lymphocytes, Safety, Advanced Solid Tumor Trial in Beijing (TIL therapy)

    Recruiting
    • Tumor Infiltrating Lymphocytes
    • +5 more
    • TIL therapy
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Dec 19, 2022

    HER2-overexpressed Advanced Solid Tumors After Progression of

    Not yet recruiting
    • HER2
    • +3 more
    • Disitamab Vedotin
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Dec 14, 2022

    Advanced Cancer, Metastatic Cancer Trial in Shanghai (biological, device, drug)

    Recruiting
    • Advanced Cancer
    • Metastatic Cancer
    • Autologous Adoptive immune cells
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Pudong Medical Center
    Jun 24, 2022

    Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +14 more
    • ELI-002 7P
    • (no location specified)
    Feb 3, 2023

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • Biopsy
    • +5 more
    • (no location specified)
    Apr 8, 2023

    Metastatic Cancer, Metastatic Breast Cancer, Metastatic Lung Cancer Trial in Mexico City (SV-101)

    Recruiting
    • Metastatic Cancer
    • +3 more
    • Mexico City, Mexico
      Hospital Diomed
    Sep 14, 2022

    Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with

    Recruiting
    • Metastatic Solid Tumor
    • +4 more
    • Recommendation for treatment with immunotherapy
    • Baltimore, Maryland
      Johns Hopkins University
    Sep 8, 2022

    Efficacy, Safety Trial (PD-L1 inhibitor)

    Not yet recruiting
    • Efficacy
    • Safety
    • PD-L1 inhibitor
    • (no location specified)
    Apr 6, 2022

    Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-927, ABBV-181)

    Active, not recruiting
    • Advanced Solid Tumors Cancer
    • Los Angeles, California
    • +21 more
    Jan 20, 2023

    Solid Tumor Trial in Shanghai (PD-1 blocking antibody)

    Recruiting
    • Solid Tumor
    • PD-1 blocking antibody
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiaotong University School of Medicine
    Oct 16, 2021

    Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +8 more
    • Imatinib Mesylate
    • Ipilimumab
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 1, 2022

    Solid Tumor, Ewing Sarcoma, Ewing's Tumor Metastatic Trial in Dallas (Vigil)

    Temporarily not available
    • Solid Tumor
    • +7 more
    • Vigil
    • Dallas, Texas
      Texas Oncology - Pediatrics
    Feb 9, 2022

    Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

    Recruiting
    • Advanced Solid Tumor
    • +24 more
    • MDNA11 Monotherapy
    • MDNA11 in combination with checkpoint inhibitor
    • Santa Monica, California
    • +7 more
    Nov 1, 2022

    Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Tumor Trial in Australia (Ipilimumab,

    Recruiting
    • Advanced Biliary Tract Cancer
    • +3 more
    • Albury, New South Wales, Australia
    • +11 more
    Oct 31, 2022

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Canada, United

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • Biopsy
    • +6 more
    • Boston, Massachusetts
    • +5 more
    Jan 7, 2023

    Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)

    Active, not recruiting
    • Ewing Sarcoma
    • +4 more
    • Allogeneic HCT
    • Donor NK Cell Infusion
    • Milwaukee, Wisconsin
    • +1 more
    Apr 5, 2022

    Advanced Solid Tumor, Breast Cancer Trial in Columbus, San Antonio, West Valley City (CFI-402257, Fulvestrant)

    Recruiting
    • Advanced Solid Tumor
    • Breast Cancer
    • Columbus, Ohio
    • +2 more
    Jul 26, 2022

    Advanced Solid Tumor, Tumor Infiltrating Lymphocytes, Treatment Side Effects Trial in Hangzhou (Tumor Infiltrating Lymphocytes)

    Recruiting
    • Advanced Solid Tumor
    • +3 more
    • Tumor Infiltrating Lymphocytes
    • Hangzhou, Zhejiang, China
      Sir Run Run Shaw Hospital, Zhejiang University, School of Medici
    Oct 12, 2021

    Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • second generation 4-1BBζ EGFR806-EGFRt
    • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
    • Seattle, Washington
      Seattle Children's Hospital
    May 2, 2022

    NSCLC, Esophageal Squamous Cell Carcinoma Trial in Chengdu (Anti-PD-1 antibody combined with Paclitaxel and carboplatin.,

    Recruiting
    • Non-small Cell Lung Cancer
    • Esophageal Squamous Cell Carcinoma
    • Anti-PD-1 antibody combined with Paclitaxel and carboplatin.
    • Surgical treatment stage
    • Chengdu, Sichuan, China
      Sichuan Cancer Hospital
    Sep 5, 2021